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Abstract
Problem: Opioid abuse may be a result of overprescribing opioids. There are no opioid
prescribing recommendations for minor gynecologic surgery. As a result, there is a wide
variation in prescribing practices at a privately-owned surgery center where excessive
opioid prescription occurs.
Methods: A quality improvement initiative with a descriptive, cohort design. A
retrospective review of medical records and telephone surveys over three months resulted
in the development of a series of posters describing prescription data for three
procedures: hysteroscopy dilation and curettage (HDC), uterine ablation (UA), and
laparoscopy (LAP). The trends and changes in opioid prescription practices were
displayed throughout the surgery center every month.
Results: A total on 526 medical records were reviewed (N=526) with HDC (n=358); UA
(n=95); and LAP (n=73), and 45 telephone surveys were completed (N=45) with HDC
(n=18); UA (n=9); and LAP (n=18). The number of patients receiving a prescription for
opioids following HDC decreased from 23.3% to 16.4% (p = .001). When opioids were
prescribed following HDC, UA, and LAP the mean milligrams of morphine equivalents
(MMEs) prescribed decreased 34%, 19%, and 14%, respectively. Results were significant
at the p < .05 level for all groups (HDC: p=.001; UA: p=.034; LAP: p= .039).
Implications for practice: Opioid prescribing following monthly publications of
prescribing practice and self-reported patient usage decreased the number of opioids
prescribed. Monitoring prescribing practices and regular patient surveys may assist in
changing prescription practices and may be a reasonable option to decrease excessive
opioid prescription at specialty surgery centers.
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Decreasing Opioid Over-Prescription Following Outpatient Gynecologic Surgery
Opioid misuse and overdose continue to be a pervasive problem in the United
States. In 2016, more than 11.5 million people reported misusing a prescription opioid
(Centers for Disease Control [CDC], 2018) and there were more than 17,000 deaths
involving a pharmaceutically manufactured opioid (Seth, Rudd, Noonan, & Haegerich,
2018). Moreover, most heroin users report first misusing prescription painkillers
(Muhuri, Gfroerer, & Davies, 2013). On October 26, 2017, the opioid crisis was declared
a public health emergency by the U.S. Department of Health and Human Services (HHS)
(HHS, 2017).
Opioids are an important modality for treating pain in the surgical patient, but are
often overprescribed following surgery (Feinberg, Chesney, Srikandarajah, Acuna, &
McLeod, 2017). Excessive prescription can lead to abuse and diversion. Opioid
prescribing recommendations for common surgical procedures have been suggested by
groups such as the Michigan Surgical Quality Collaborative (Michigan Surgical Quality
Collaborative, 2018) and the Center for Opioid Research and Education (Center for
Opioid Research and Education, 2018). However, these recommendations are conflicting
and do not include outpatient gynecologic procedures.
The aims of this project were to establish baseline data on opioid prescription and
consumption; disseminate the data to surgeons and nurses; and decrease opioid overprescription following outpatient gynecology surgery. This project was guided by the
following study questions:
For women undergoing outpatient gynecological procedures at a Midwest Multispecialty
Surgery Center, aged 18 and older:
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1. What percentage of patients received a prescription for an opioid at discharge
from July 1st – September 30th following hysteroscopy dilation and curettage
(HDC)?
2. When opioids were prescribed, what was the median milligram of morphine
equivalents (MME) prescribed from July 1st – September 30th for HDC, uterine
ablation (UA), and laparoscopy (LAP), respectively?
3. For those prescribed opioids, what was the self-reported MME consumed July 1st
– September 30th?
Data from the three months prior to the intervention was compared with data from
the three months following the intervention (February 1st – April 30th) for study questions
1 and 2. Results were stratified by procedure type and answered the following study
questions:
With dissemination of information on opioid consumption was there:
4. a decrease in the percentage of patients who received a prescription for opioids
following HDC?
5. a decrease in the mean MME prescribed, when opioids were prescribed, following
HDC, UA, and LAP, respectively?
Literature Review
A literature search was performed of MEDLINE, Cochrane, and CINAHL
databases using Ebscohost. The databases were searched using the terms: “opioid” and
“postoperative”, not “chronic”, with truncation from August 31, 2013 to August 31,
2018. The database search identified 4,603 articles. After title review, 71 articles were
selected for abstract review based on relevance to current prescribing trends after
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outpatient surgery, historical perspective of the opioid crisis, and interventions to
decrease inappropriate opioid prescription after surgery. Nine study abstracts and two
systematic review abstracts were initially found examining opioid medication use
following discharge. Two studies were excluded that included only pediatric
populations, and another two were excluded that reported only on inpatient surgeries.
One study was excluded because full text was not available through interlibrary loan.
The percentage of opioids used after surgery ranged from 5.6% to 58% of the
total amount prescribed for adult populations (Feinberg, et. al., 2018; Bicket, Long,
Provonost, Alexander, & Wu, 2017; Tan et al., 2018; Theils et al., 2018; Fujii et al.,
2018; Hill, McMahon, Stucke, & Barth, 2017). All studies of adult patients reported
patients were using significantly fewer opioids than prescribed. However, one study of
pediatric patients, included in the Feinberg et al. (2018) systematic review, found
pediatric spinal fusion patients consumed 90.1% of the opioids prescribed.
All studies in the review included patients from more than one type of surgery and
found that median opioid consumption varied by procedure. Most studies reported doses
of opioid prescription in MMEs (appendix A) (Feinberg, et. al., 2018; 2018; Fujii et al.,
2018; Tan et al., 2018; Thiels et al., 2018). In general, people undergoing orthopedic
surgery used a greater number of MMEs than those undergoing other types of surgeries
(Hill et al., 2017; Thiels et al., 2018). Only one study included median MME prescribed
after hysteroscopy, but it did not include data on consumption for any gynecology
procedures due to resource limitations (Fujii et al., 2018).
Consistently, less than 10% of patients surveyed reported disposing of excess pills
in a manner approved of by the U.S. Food and Drug Administration (FDA) (Bicket et al,
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2017; Hill et al., 2017; Thiels et al., 2018). FDA-approved disposal methods include:
returning the medication to a drug take-back location, mixing with an inedible substance
and disposing of in the household trash, or, when other options are not available, flushing
down the toilet (U.S. Food and Drug Administration, 2018).
Excess opioid prescription after surgery poses two risks: misuse and diversion.
The risk of developing an opioid misuse disorder after surgery is low (0.2%), but the risk
of developing new, persistent use is appreciable and is not significantly different between
major and minor surgeries (5.9%-6.5%) (Brat et al., 2018; Brummett et al., 2017).
Diversion is common, 40.8% of the 11.5 million adults in the U.S. who are misusing
prescription opioids obtained the medication for free from friends or family, primarily by
theft (Han et al., 2017). Additionally, initiation of heroin use is 19 times more likely in
people who have misused prescription pain medications (Muhuri, Gfroerer, & Davies,
2013).
The opioid crisis has resulted from a complex interplay of social and political
factors and has claimed more lives than the HIV epidemic of the 1980s (Theisen, Jacobs,
Macleod, & Davies, 2018). In 1990s, the American Pain Society proposed pain as the
“fifth vital sign.” Their aim was to make invisible suffering visible and provide a
standardized pain rating scale (Baker, 2017). Not long after, the Joint Commission, in
conjunction with the National Pharmaceutical Council, released guidelines on assessing,
reporting, and treating pain (National Pharmaceutical Council, 2001). Five years later,
the Centers for Medicare and Medicaid Services (CMS) implemented Hospital Consumer
Assessment of Healthcare Providers and Systems (HCAHPS) surveys to assess healthcare
experience from the patient’s perspective. Three questions on the survey related to pain
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management and control (CMS, 2018). The next year, hospital reimbursement from
CMS was related to HCAHPS scores (Theisen et al., 2018).
At the same time regulations were incentivizing pain treatment, pharmaceutical
companies were aggressively marketing drugs like OxyContin directly to consumers
(Haffajee & Mello, 2017). From 1999 to 2015, the amount of opioid prescribed by
physicians tripled (Guy et al., 2017). Since 2004, Purdue Pharma, Cardinal Health, Insys
Therapeutics, McKesson, and Mallincrodt have settled seven state/local lawsuits and four
federal suits for misbranding, false-advertising, and kickbacks to prescribers (Haffajee &
Mello, 2017). Paradoxically, restrictions on scheduled medication prescribing may have
contributed to overprescribing. Until 2015, the only way to give a patient a prescription
for an opioid in a Midwestern state was with a hand-written prescription. Surgeons likely
provided written prescriptions for opioids after surgery “just in case” since the logistics
of obtaining a prescription after discharge would be difficult for both patient and
provider.
Since the release of the CDC’s Opioid Prescribing Guidelines for Chronic Pain in
2016, rate of high dose prescription (> 90 MMEs per day), concurrent benzodiazepine
prescription, and overall rate of opioid prescription has fallen in the U.S. (Bohnert, Guy,
& Losby, 2018). However, the CDC guidelines do not address opioid prescribing after
surgery. Guidelines for surgical procedures have been proposed by groups such as the
Michigan Surgical Quality Collaborative (Michigan Surgical Quality Collaborative,
2018) and the Center for Opioid Research and Education (Center for Opioid Research
and Education, 2018). These guidelines made recommendations for common surgical
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procedures, but do not include any gynecologic procedures commonly performed on an
outpatient basis.
At the institutional level, several quality improvement initiatives have
successfully resulted in decreased initial opioid prescription. Hill, Stucke, Mcmahon,
Beeman, and Barth (2018), presented institution-specific data gathered in a previous
study on opioid prescription variability and over prescription following surgery to their
surgeons during grand rounds. In their educational intervention, they encouraged
prescribers to recommend acetaminophen and NSAIDs first, and only use opioids for
breakthrough pain. After the intervention, opioid prescription fell 53%, and the number
of refills requested by patients did not increase (Hill, Stucke, McMahon, Beeman, &
Barth, 2018). Another study found implementing evidence-based opioid prescription
guidelines for one surgery had unintended effects on prescription practices following
other types of surgeries, and decreased prescription in four other procedures without
significantly increasing requests for refills (Howard, et al., 2018).
Chiu, Jean, Hoag, Freedman-Weiss, Healy, and Pei examined the effects of
lowering the default number of opioid pills in the electronic medical record (EMR) when
prescribing discharge analgesics (Chiu et al., 2018). In this study, the autopopulated
number of pills in the EMR was decreased from 30 to 12, forcing prescribers to manually
enter a number greater than 12, if additional pills were required. After the EMR change,
the median number of opioid pills prescribed fell from 30 to 20, without a statistically
significant change in refill requests (Chiu et al., 2018).
One theme emerged from the literature review regarding a lack of patient
education on appropriate disposal of unused opioids. Since pain tolerance varies from
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person to person, it is impossible to predict the exact number of opioids required for each
person. Even if initial opioid prescription was decreased, some patients would still have
excess pills. A quality improvement initiative at Washington University in St. Louis
sought to address this problem with a low cost, easily implementable intervention (Hasak,
et al., 2017). The intervention included dissemination of an opioid-disposal brochure to
patient at the time surgery was scheduled and again at the time of discharge (Hasak et al.,
2017). After the intervention, the number of patients who reported disposing of their
unused medications appropriately doubled (Hasak et al., 2017).
This project used a Plan-Do-Study-Act framework for implementing change. This
four-step cycle emphasizes continuous improvement of a product, process, or service.
During the first step, plan, goals and success metrics are identified. During the second
step, do, the plan is implemented. During the third step, study, outcomes are measured
and successes and failures are identified. During the last step, act, the intervention is
scaled-up or the goals and methods are adjusted and the cycle begins again (Deming
Institute, 2018).
Method
Design
This quality improvement project utilized a descriptive cohort design for the
survey portion and an uncontrolled before-and-after intervention study design for
tracking prescribing changes. A retrospective medical record review of all eligible charts
from July 1- September 30, 2018 was completed. Two attempts were made to contact all
patients identified by the review as having met the inclusion criteria and having been
prescribed opioids at discharge by phone. The results of the phone survey were used to
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develop educational posters for prescribers. After the posters were displayed, another
retrospective medical record review was completed to examine changes in prescribing
patterns. The post-intervention data was collected from February 1- April 30, 2019.
Setting
The setting for this project was a privately-owned ambulatory surgery center
(ASC) in a Midwestern, suburban area. The center was originally founded as a
gynecology-only facility, and, despite expanding to include other specialties, maintains a
large percentage of gynecology cases, approximately 1200 cases per year. The facility is
part of a larger network of ASCs and is not part of an academic medical center.
Sample
A convenience sample of female patients from July 1, 2018 through September
30, 2018, who were 18-years of age and older, who underwent HDC, UA, or LAP, and
whose procedure was performed by an obstetrician/gynecologist at the surgery center.
Exclusionary criteria included self-report of opioid use as a home medication on the
admission record, other gynecological surgeries, or age less than 18-years. For the
survey phone call, convenience sampling was also used. Two attempts were made to
contact all patients identified in the chart review as having received an opioid
prescription at discharge. Exclusionary criteria for the phone survey included: nonEnglish speaking or no working phone number listed in the chart.
Procedures
A team was assembled including nurses, physicians, and the board of directors at
the Midwestern surgical center. The proposal was first submitted for feedback on
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feasibility and appropriateness to the board in September, 2018. Feedback was
incorporated into the project proposal.
Prior to disseminating data, a medical record review and telephone survey
compared opioid prescription with opioid consumption. All patients logged received a
random and unique identifier (1-1100) using randomizer.org. Since it was necessary to
link patients who received an opioid to the information collected from their medical
record, a hand-written key was created listing each participant’s identifier, name, and
phone number. The key was kept in a locked box within a locked cabinet in the medical
records storage room. Only the coordinator of the project had access to this box. The
key will be destroyed by shredding in 2022, per recommendation of the institutional
review board (IRB). Data extracted from the medical record included: demographics data
(age, race, date of surgery, procedure type, physician), type of opioid prescribed, dosage,
and number of pills.
After the chart review was completed, up to three attempts were made to contact
eligible participants (those that received an opioid and did not meet any exclusionary
criteria) by phone. If contact was made, and patients verbally agreed to participate in the
survey over the phone, three questions were asked and recorded. Questions included: did
they fill their prescription; how many pills were left over after their surgical pain
resolved; and did they receive disposal instructions?
After all information was collected from the medical records and patient surveys,
the amount of opioid prescribed and consumed was converted to MMEs. For those
prescribed opioids, the median number of MMEs prescribed was compared the median
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number of MMEs consumed. All data collected was stored on a password-protected
computer.
Once the data was collected and analyzed it was disseminated to OB/GYNs and
nurses along with information on the consequences of over prescription through
handouts, and via signage in the locker rooms and break room at the project site.
Dissemination of information took place in January 2019, and continued throughout the
duration of the study. Signage was updated monthly.
To determine if dissemination of this information resulted in any practice change,
opioid prescribing was tracked for three months after the education was provided:
February 1 through April 30, 2019. The following variables were compared pre- and
post-intervention:
1. Percentage of patients receiving opioid prescription following HDC
2. MMEs prescribed, when opioids were prescribed, following HDC, UA, and LAP
Data from the chart reviews was compared pre/post intervention using chi squared and ttests.
Approval Process
This project was approved by the board of directors and compliance department at
the project site on September 17, 2018, and by the University IRB in December, 2019.
During the board meeting, one consideration of concern was that patients receiving the
phone survey may believe their personal phone numbers had been “sold” to an outside
company. To mitigate this risk, the person conducting the phone calls identified herself as
an employee of the surgery center since this was a fact. Another risk was the potential
for breach of confidentiality. To prevent this, all personal identifiers were removed from
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the data collected. The projected benefits of this project were numerous and included:
increased awareness of the consequences of over-prescription; development of
gynecology specific recommendations for postoperative opioid prescription; a decrease in
over prescription; and fewer unused pills resulting in less potential for misuse and
diversion.
Results
A total of 526 medical records were reviewed (N=526). There were 203 patients
identified for the pre-intervention HDC group. Ten medical records were not available
leaving 193 medical records reviewed for the pre-intervention HDC cohort (n=193).
There were 179 identified for the post-intervention HDC group. Eleven medical records
were not available, and three patients were excluded for opioid use on admission, leaving
165 medical records for the post-intervention HDC cohort (n=165). For those receiving a
UA, 47 patients were initially identified for the pre-intervention group. One medical
record was unavailable and one patient was excluded for opioid use on admission,
resulting in 45 medical records for the pre-intervention UA cohort (n=45). For the
postintervention group, 50 medical records were identified, and all met the inclusion
criteria for the post-intervention UA cohort (n=50). For LAP, 40 medical records were
identified for the pre-intervention cohort (n=40) and 33 medical records were identified
for the post-intervention LAP cohort (n=33). Finally, 45 patients consented to, and
participated in the post-surgical telephone survey (N=45).
There were no statistically significant differences between the pre-intervention
cohorts and the post-intervention cohorts in race or age. Most patients were Caucasian
(n= 475, 84.8% – 93.3%), followed by Black (n= 27, 0% - 7.3%), then Asian (n= 12, 0%
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- 7.5%), and Hispanic (n=7, 0% - 4.4% (appendix B). All patients were female. The range
of ages was 20 to 87 years. The mean age for HDC was 50.8 years (SD=11.4) and 49.2
years (SD=11.4) in the pre- and post- intervention cohorts respectively. For the UA
cohort, the mean age for the pre-intervention cohort was 43.6 years (SD=6) and postintervention was 42.4 years (SD=5.7). Finally, the average age for the pre-intervention
LAP cohort was 38.3 years (SD=10.3) and post-intervention was 37.4 years (SD=9.0)
(appendix B).
In the pre-intervention cohorts, there were no reports of unrelieved pain on
postoperative day one for any patient who underwent HDC (n= 193) regardless of receipt
of opioid prescription at discharge. Of the HDC patients, 45 received a prescription for
opioids (23.3%). When opioids were prescribed, the median amount of MMEs prescribed
was 75 (M=85.6; SD=47.1). Of those 45 patients, 18 (40%) consented to and completed
the telephone survey. The median number of MMEs reported to be consumed by the
surveyed group was zero. For those who underwent a UA, 36 (80%) patients received a
prescription for opioids following the procedure. For those patients the median amount of
MMEs prescribed was 112.5 (M=119.2; SD=53.4). Of the 36 patients, nine consented to
and completed the telephone survey (25%). The median MMEs reported to be consumed
by those surveyed was 60 (M=68.5; SD=60.4). Most patients (85%) who underwent a UA
reported taking 100 MMEs or fewer. Finally, 38 (95%) patients received a prescription
for opioids following LAP. For those patients, the median MMEs prescribed was 150
(M=142.2; SD=49.3). Of those patients, 18 (47%) consented to the telephone survey. The
median MMEs consumed by those surveyed was reported to be 33.7 (M=43.4; SD=42.7)
(appendix C). Most patients (90%) took fewer than 90 MMEs following LAP.
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Chi-squared analysis was used to compare the percentage of patients who
received an opioid at discharge following HDC before and after the intervention and to
compare patient report of uncontrolled pain on post-operative day one or two follow up
call before and after the intervention. The percentage of patients who received an opioid
at discharge following HDC decreased from 23.3% to 16.4% (p = .001). Most of the
decreased prescription for HDC was seen in the final month of the chart review (appendix
D). In fact, there was only one prescription for opioids following HDC in April. There
was no statistically significant difference in patient report of uncontrolled pain on postoperative day one or two follow-up call before and after the intervention (p = .2974)
(appendix F).
To compare the mean MME prescribed pre- and post-intervention, an unpairedsamples t test was performed for each of the three procedures. The mean MME
prescribed for HDC decreased 34% from 85.6 (SD=47.1) in the pre-intervention cohort to
56.4 (SD=31.9) in the post-intervention cohort. The difference between the two means
was statistically significant at the .05 level (t=3.131, dƒ=68.8717, p=.001). For the UA
cohorts, the mean MME prescribed decreased 19% from 119.2 (SD=53.4) preintervention to 96.6 (SD=43.6) post-intervention. The difference between the two means
was statistically significant at the .05 level (t=2.008, dƒ=67.7.7202, p=.034). Last, in the
LAP cohort, the mean MME prescribed decreased 14% from 142.4 (SD=49.3) preintervention to 121.7 (SD=46.4) post-intervention. The difference between these two
means was also statistically significant at the .05 level (t=1.746, dƒ=67.128, p=.039)
(appendix E).
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Discussion
Providing monthly data to the outpatient surgical group appeared to be effective
in changing prescribing opioid habits for HDC, UA, and LAP patients. Based on the
results of this study, the recommended number of MMEs to be prescribed following
outpatient gynecologic surgery is: Zero for HDC procedures, 100 (or 13 Percocet, 5 mg
equivalents) for UA procedures, and 90 (or 12 Percocet, 5 mg equivalents) for LAP
procedures. After posters of patient survey data were placed throughout the surgical
center and distributed to physicians and nurses, the amount of opioids prescribed fell
significantly for all three procedures. For HDC, the number of patients who received an
opioid at discharge decreased 6.9% (p = .001). When opioids were prescribed after UA
and LAP the mean MME prescribed decreased 19% and 14% (p=.034; LAP: p= .039),
respectively. Interestingly, the longer the posters were displayed, the greater decrease in
opioid prescription. In fact, for HDC, there was no significant decrease in the percentage
of patients who received a prescription until the third and final month of the study when
only one patient received a prescription for opioids. The results of this project were
consistent with opioid quality initiatives attempted at other institutions.
One common apprehension voiced by prescribers was concern about the risk of
under prescribing and uncontrolled pain. Despite the reductions in opioid prescriptions
seen in this project, there was no increase in reports of uncontrolled pain or requests for
additional medications. This is consistent with previous studies. While pain, especially
post-surgical pain is of concern, dispelling the myth that all post-surgical patients need an
opioid is recommended.
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Several practice guidelines for postsurgical opioid prescription have been released
and revised in the last few years, however, these large-scale studies did not include
specialty surgical procedures performed on an outpatient basis. A goal for future practice
should include the development of practice guidelines for surgical specialty procedures,
such as gynecological procedures, based on evidence. Often specialty procedures are
performed in outpatient surgical centers not affiliated with academic hospitals, making
research support difficult. Recommendations for further study include larger scale studies
for specialty-specific surgeries and postoperative pain prescribing habits for minor to
major procedures and in different types of surgical settings. Further study is also needed
in patient disposal of unused opioids since the overall aim is to decrease the number of
opioids available for public consumption.
Conclusion
This outpatient women’s surgical center established an opioid prescription
practice for postsurgical HDC, UA, and LAP pain control. While postoperative surgical
pain is of concern, there are procedures performed with little resulting pain. Improved
knowledge regarding the types of procedures not needing an opioid or needing only a few
opioids may decrease the number of opioids prescribed. Prescribing healthcare providers
can play a vital role in decreasing the number of available opioids to the general public.
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Milligrams Morphine Equivalent (MME) Conversion Chart for Selected Opioids
Type of Opioid (unit of
measurement)

MME Conversion Factor

Codeine (mg)
Hydrocodone (mg)
Morphine (mg)
Oxycodone (mg)
Tramadol (mg)

0.15
1
1
1.5
0.1

Reference
Centers for Medicare and Medicaid Services. (2016). Opioid oral morphine milligram
equivalent (MME) conversion factors. Retrieved from
https://www.cms.gov/Medicare/PrescriptionDrugCoverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQConversion-Factors-Aug-2017.pdf
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Appendix B
Table 1.
Patient Characteristics Before and After Intervention
Pre -Intervention

Mean Age (SD)

Post-Intervention

HDC
(n=193)

UA
(n = 45)

LAP
(n = 40)

HDC
(n = 165)

UA
(n = 50)

LAP
(n = 33)

50.8
(11.4)

43.6 (6.0)

38.3 (10.3)

49.2 (11.4)

42.4 (5.7)

37.4 (9.0)

.1864

.3202

.6954

p value
Race
American
Indian/
Alaska
Native
p value

0; 0%

0; 0%

0; 0%

0; 0%
1.0

0; 0%
1.0

0; 0%
1.0

Asian
p value

2; 1.0%

0; 0%

3; 7.5%

6; 3.6%
.0949

0; 0%
1.0

1; 3.0%
.4301

Black or
African
American
p value

9; 4.7%

1; 2.2%

2; 5%

12; 7.3%
.3543

0; 0%
.2943

3; 9.1%
.5025

2; 1.0%

2; 4.4%

0; 0%

3; 1.8%
.5167

0; 0%
.1360

0; 0%
1.0

Native
Hawaiian
or Pacific
Islander
p value

0; 0%

0; 0%

0; 0%

0; 0%
1.0

0; 0%
1.0

0; 0%
1.0

White
p value

177;
91.7%

42; 93.3%

35; 87.5%

143; 86.7%
.1261

50
.0643

28; 84.8%
.7403

Not
Recorded
p value

3; 1.6%

0; 0%

0; 0%

1; 0.6%
.3748

0; 0%
1.0

1; 3%
.2734

Hispanic
or Latino
p value
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Appendix C
Table 2.
Third Quarter 2018 Survey of Patients Prescribed Opioids
HDC
(n = 45)

UA
(n = 36)

LAP
(n = 38)

18 (40%)

9 (25%)

18 (47%)

Prescribed MME
Mean (SD)
Median

85.6 (47.1)
75

119.2 (53.4)
112.5

142.4 (49.3)
150

Consumed MME
Mean (SD)
MME

24.3 (54.3)
0

68.5 (60.4)
60

43.4 (42.7)
33.75

100

90

Number of patients contacted
n (%)
Prescription vs Consumption

MMEs consumed
by 85th percentile
and below

Note. Two surveyed patients in the UA group could not remember how many opioid pain
pills were taken after discharge following their procedure.
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Appendix D
Table 3.1.
Percentage of Patients Receiving an Opioid at Discharge Pre/Post-intervention
Following HDC, by Month
Preintervention
n = 193

Feb
n = 54

March
n = 49

April
n = 62

N

45

13

13

1

Postintervention
Feb – March
Combined
27

%

23.3

24.1

26.5

1.6

16.4

.6272

.6400

.0001

0.001

p value
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Appendix E
Table 3.2
Mean MME when Opioids were Prescribed, Pre/Post-intervention
Preintervention Postintervention
HDC
n

45

27

mean

85.6

56.4

standard
deviation

47.1

31.9

36

40

mean

119.2

96.6

standard
deviation

53.4

43.6

38

32

mean

142.4

121.7

standard
deviation

49.3

46.4

Decrease

p value

29.2

.001

22.6

.034

19.7

.039

UA
n

LAP
n

Note. The mean MME prescribed for HDC decreased from 85.6 (SD=47.1) in the preintervention cohort to 56.4 (SD=31.9) in the post-intervention cohort. The difference
between the two means was statistically significant at the .05 level (t=3.131, dƒ=68.8717,
p=.001). For the UA cohorts, the mean MME prescribed decreased from 119.2
(SD=53.4) pre-intervention to 96.6 (SD=43.6) post-intervention. The difference between
the two means was statistically significant at the .05 level (t=2.008, dƒ=67.7.7202,
p=.034). Last, in the LAP cohort, the mean MME prescribed pre-intervention was 142.4
(SD=49.3) and compared to the mean in the post-intervention cohort of 121.7 (SD=46.4).
The difference between these two means was also statistically significant at the .05 level
(t=1.746, dƒ=67.128, p=.039).
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Appendix F
Table 3.3.
Pain Controlled on Postoperative Day One: All Patients

No report of
uncontrolled pain
n
%
Reported
uncontrolled Pain
n
%
p value

Preintervention
n = 278

Postintervention
n = 248

277
99.6

245
98.8

1
0.4%

3
1.2%
.2974

Note. No report of uncontrolled pain included all patients marked on the day one or two
postoperative call as “pain unrelieved with medications.” Everyone else, including those
who were not available by phone were included in the “No report of uncontrolled pain.”
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Appendix G
Figure 1.
Number of Opioid Pain Pills Prescribed Before and After Intervention
20
18
16
14
12
10
8
6
4
2

0

0
HDC

UA
Preintervention

Postintervention

LAP
Recommendation

Figure 4. This is a chart of the MMEs converted into their Percocet 5mg equivalents
using the “MME Equivalency Chart” provided by the Centers for Medicare and Medicaid
Services. (2016). Opioid oral morphine milligram equivalent (MME) conversion factors.
Retrieved from https://www.cms.gov/Medicare/PrescriptionDrugCoverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQConversion-Factors-

